Business

Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports

22601469
Merck is nearing a roughly $10 billion deal to buy lung disease-focused biotech Verona Pharma, the Financial Times reported on Wednesday.

SEE MORE

More